Header Logo

Connection

Matthew Meriggioli to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Matthew Meriggioli has written about Drug Administration Schedule.
Matthew Meriggioli
Connection Strength
0.078
Drug Administration Schedule
  1. Mycophenolate mofetil in dermatomyositis: is it safe? Neurology. 2006 Apr 25; 66(8):1245-7.
    View in: PubMed
    Score: 0.064
  2. Etanercept treatment in corticosteroid-dependent myasthenia gravis. Neurology. 2004 Dec 28; 63(12):2390-2.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.